Putting the award page together from the records…
Putting the award page together from the records…
Battelle National Biodefense Institute, LLC received this contract from Sci Tech Acq Div, Office of Procurement Operations: $2.00M obligated so far for general science and technology r&d services; general science and technology; basic research. It runs to 2027-07-02.
Key facts · data as of Oct 22, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 22, 2026.
Cite this page: SpendQuery, Award 70RSAT26FR0000017, data as of Oct 22, 2026, https://spendquery.com/award?id=CONT_AWD_70RSAT26FR0000017_7001_HSHQDC15C00064_7001
Battelle National Biodefense Institute, LLC: all federal awards · Department of Homeland Security: spending · Sci Tech Acq Div: what it buys · The follow-on: recompete brief
NBACC II EXTENSION WORK FOR OTHERS (WFO) TASK ORDER FOR THE EQUIPMENT ACQUISITION AND DEMONSTRATION PROJECT PLANNING FOR GENERATIVE UNCONSTRAINED INTELLIGENT DRUG ENGINEERING (GUIDE), PHASE II.
Up for re-bid: ends 2027-07-02. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
1 subaward totaling $148.5K (7.4% of what was obligated), as Battelle National Biodefense Institute, LLC reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Franklin Young International, Incorporated | $148.5K | 1 | CA | 2026-09-02 | 2026-09-02 |
| Date | To | Amount | For |
|---|---|---|---|
| 2026-09-02 | Franklin Young International, Incorporated | $148.5K | PURCHASE OF THE MFT LABCHIP INSTRUMENT. |
1 action since 2026-07-02. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-07-02 | 0 | $2.00M | NBACC II EXTENSION WORK FOR OTHERS (WFO) TASK ORDER FOR THE EQUIPMENT ACQUISITION AND DEMONSTRATION PROJECT PLANNING FOR GENERATIVE UNCONSTRAINED INTELLIGENT DRUG ENGINEERING (GUIDE), PHASE II. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗